Facial asymmetry in head and neck rhabdomyosarcoma survivors-Reference-Cited by-同舟云学术

Facial asymmetry in head and neck rhabdomyosarcoma survivors

Published:2017-04-19 Issue:10 Volume:64 Page:e26508
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Schoot Reineke A¹,Hol Marinka L. F.²,Merks Johannes H. M.¹,Suttie Michael³,Slater Olga⁴,van Lennep Marinde¹,Hopman Saskia M. J.¹,Dunaway David⁵,Syme-Grant Jonathan⁵,Smeele Ludi E.²⁶,Zwinderman Koos H.⁷,Caron Huib N.¹,Hammond Peter³

Affiliation:

1. Department of Paediatric Oncology; Emma Children's Hospital; Academic Medical Centre; Amsterdam The Netherlands

2. Department of Oral and Maxillofacial Surgery; Academic Medical Centre; Amsterdam The Netherlands

3. Nuffield Department of Obstetrics and Gynaecology; University of Oxford; Oxford UK

4. Department of Paediatric Oncology; Great Ormond Street Hospital for Children NHS Foundation Trust; London United Kingdom

5. Craniofacial Unit; Great Ormond Street Children's Hospital for Children NHS Foundation Trust; London United Kingdom

6. Department of Head and Neck Surgery; Antoni van Leeuwenhoek The Netherlands Cancer Institute; Amsterdam The Netherlands

7. Department of Clinical Epidemiology and Bio-Statistics; Academic Medical Centre; Amsterdam The Netherlands

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.26508/fullpdf

Reference21 articles.

1. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study;Oberlin;J Clin Oncol,2012

2. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group;Raney;J Clin Oncol,2011

3. Adverse events in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treament;Schoot;Eur J Cancer,2015

4. Parameningeal rhabdomyosarcoma in pediatric age: a result of a pooled analysis from North American and European cooperative groups;Merks;Ann Oncol,2014

5. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects;Childs;Int J Radiat Oncol Biol Phys,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study;Pediatric Blood & Cancer;2023-05-30

2. Abdominal Tumors;Surgical Clinics of North America;2022-10

3. Static and Motion Facial Analysis for Craniofacial Assessment and Diagnosing Diseases;Annual Review of Biomedical Data Science;2022-08-10

4. Radiation Therapy in the Treatment of Head and Neck Rhabdomyosarcoma;Cancers;2021-07-16

5. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology;Pediatric Radiology;2021-06-17